[1]
PadoanA., SeragliaR., FogarP., SpertiC., MozS., GrecoE., MarchetA., ZambonC., NavagliaF., di ChiaraA., NittiD., PedrazzoliS., PavanelloG., PasqualiC., PlebaniM. and BassoD. 2012. MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3. JOP. Journal of the Pancreas. 13, 5S (Sep. 2012), 630. DOI:https://doi.org/10.6092/1590-8577/998.